Sarepta Therapeutics, Inc. — Director's Dealing 2012

Aug 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2012-08-23

Reporting Person: JACOBSEN MICHAEL A (VP of Finance and PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-23	Common Stock	A	7500	—	Acquired	7500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-23	Stock Option (Right to Buy)	$10.08	A	48500	Acquired	2022-08-23	Common Stock (48500)	Direct

Footnotes

F1: Restricted stock units (RSUs). 25% of the RSUs will vest on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the RSUs will vest in equal monthly installments thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. The RSUs are subject to acceleration provisions in the event of certain termination scenarios as more specifically set forth in an agreement between the Issuer and the Reporting Person.

F2: 25% of the shares subject to the option will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.